This chart shows the drugs with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Luxe…
Which pharmaceutical drugs have the most drug patents in Luxembourg? Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Spain? Read Post »
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on DrugP…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Romania? Read Post »
GRALISE (gabapentin) Almatica Patent: 6,723,340 Expiration: Oct 25, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of October 24, 2021 Read Post »
Annual Drug Patent Expirations for TRULANCE Trulance is a drug marketed by Salix and is included in one NDA. It is available from two suppliers. There are eight patents protecting…
The post New patent for SALIX drug TRULANCE appeared first on DrugPaten…
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Vanda Pharms drug HETLIOZ LQ appeared first on DrugPatentW…
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Vanda Pharms drug HETLIOZ LQ appeared first on DrugPatentW…
Annual Drug Patent Expirations for IMCIVREE Imcivree is a drug marketed by Rhythm and is included in one NDA. There are two patents protecting this drug. This drug has forty-three…
The post New patent for Rhythm drug IMCIVREE appeared first on DrugPate…
Annual Drug Patent Expirations for IMCIVREE Imcivree is a drug marketed by Rhythm and is included in one NDA. There are two patents protecting this drug. This drug has forty-three…
The post New patent for Rhythm drug IMCIVREE appeared first on DrugPate…
Get new actionable insights and updates from BiotechBlog
